Suppr超能文献

内皮素受体阻断对大鼠体内胎儿动脉导管收缩的抑制作用。

Inhibition of in vivo constriction of fetal ductus arteriosus by endothelin receptor blockade in rats.

作者信息

Momma Kazuo, Nakanishi Toshio, Imamura Shinichiro

机构信息

Department of Pediatric Cardiology, The Heart Institute of Japan, Tokyo Women's Medical University, Tokyo, Japan.

出版信息

Pediatr Res. 2003 Mar;53(3):479-85. doi: 10.1203/01.PDR.0000049516.70216.2E.

Abstract

The fetal ductus can be constricted by drugs, including cyclooxygenase inhibitors (indomethacin), nitric oxide synthesis antagonists [N-nitro-L-arginine monomethyl ester (L-NAME)], and glucocorticoid hormones (dexamethasone). Constriction of the fetal ductus by endothelin (ET) 1 was reported in an in vitro study. We studied the preventive effect of a dual ET receptor antagonist (bosentan) and a selective ET-A blocker (CI-1020) on pharmacologic fetal ductal constriction in rats. Near-term pregnant Wistar rats at d 21 and preterm rats at d 19 were used. The fetal ductus was constricted by four medications: orogastric administration of indomethacin (10 mg/kg) on fetal d 21, orogastric indomethacin 1 mg/kg combined with muscular injection of L-NAME (10 mg/kg) on fetal d 21, and muscular injection of L-NAME or dexamethasone (1 mg/kg) on fetal d 19. Bosentan (0.1, 1, 10, or 100 mg/kg) was injected intraperitoneally either simultaneously with indomethacin, L-NAME, or dexamethasone, or 4 h after administration of 10 mg/kg indomethacin. CI-1020 (0.01, 0.1, 1, or 10 mg/kg) was injected intraperitoneally simultaneously with indomethacin. After maternal atlas dislocation, cesarean section, fetal whole-body freezing, and cutting on the freezing microtome, measurements were made of the inner diameters of the ductus, main pulmonary artery, and ascending aorta. Bosentan blocked fetal ductal constriction by indomethacin, indomethacin plus L-NAME in the near-term rats, and constriction by L-NAME and dexamethasone in the preterm rats dose dependently. Fetal ductal constriction was nearly completely blocked by simultaneously administered 100 mg/kg of bosentan or 10 mg/kg of CI-1020. Dual ET receptor antagonist (bosentan) and selective ET-A blocker (CI-1020) prevent constriction of the fetal ductus arteriosus induced by ductus-constricting agents in rats, indicating that ET and ET-A receptors are essential in fetal ductal constriction.

摘要

胎儿动脉导管可被包括环氧化酶抑制剂(吲哚美辛)、一氧化氮合成拮抗剂[N-硝基-L-精氨酸甲酯(L-NAME)]和糖皮质激素(地塞米松)在内的药物所收缩。一项体外研究报道了内皮素(ET)-1可使胎儿动脉导管收缩。我们研究了双重ET受体拮抗剂(波生坦)和选择性ET-A受体阻滞剂(CI-1020)对大鼠药物性胎儿动脉导管收缩的预防作用。选用妊娠第21天的近足月Wistar大鼠和妊娠第19天的早产大鼠。通过四种药物使胎儿动脉导管收缩:在胎儿第21天经口胃给予吲哚美辛(10mg/kg);在胎儿第21天经口胃给予吲哚美辛1mg/kg并肌肉注射L-NAME(10mg/kg);在胎儿第19天肌肉注射L-NAME或地塞米松(1mg/kg)。波生坦(0.1、1、10或100mg/kg)在给予吲哚美辛、L-NAME或地塞米松的同时腹腔注射,或者在给予10mg/kg吲哚美辛4小时后腹腔注射。CI-1020(0.01、0.1、1或10mg/kg)在给予吲哚美辛的同时腹腔注射。在母鼠寰椎脱臼、剖宫产、胎儿全身冷冻并在冷冻切片机上切片后,测量动脉导管、主肺动脉和升主动脉的内径。波生坦剂量依赖性地阻断了近足月大鼠中吲哚美辛、吲哚美辛加L-NAME所致的胎儿动脉导管收缩以及早产大鼠中L-NAME和地塞米松所致的收缩。同时给予100mg/kg波生坦或10mg/kg CI-1020可几乎完全阻断胎儿动脉导管收缩。双重ET受体拮抗剂(波生坦)和选择性ET-A受体阻滞剂(CI-1020)可预防大鼠中由动脉导管收缩剂诱导的胎儿动脉导管收缩,表明ET和ET-A受体在胎儿动脉导管收缩中起重要作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验